Literature DB >> 8426978

Factors associated with high-quantity prescriptions of benzodiazepines in Sweden.

D Isacson1, K Bingefors, M Wennberg, M Dahlström.   

Abstract

An important aspect, when discussing the prescribing and use of psychotropics, is the amount of drug prescribed at each visit. In this study the Swedish Diagnosis and Therapy Survey was used in order to analyze high-quantity prescriptions of benzodiazepines. The total amount of benzodiazepines prescribed--measured as defined daily doses (DDD)--was calculated for each visit. Prescriptions with quantities equal to or greater than the 90th percentile applied on the distribution of prescribed DDD per visit were defined as high-quantity prescriptions. Using this definition, prescriptions on 200 DDD or more--14.9% of all--were classified as high-quantity prescriptions. In the analysis the proportions of high-quantity prescription in different subgroups were compared. The study showed that there was a strong relationship between age of the patient and high-quantity prescriptions while the sex of the patient was of minor importance. Doctors specializing in internal medicine and psychiatrists prescribed high-quantity prescriptions to a greater extent than other doctors but differences with regard to the doctor's ages were small. Patients with sleeping disturbances obtained high-quantity prescriptions to a greater extent than other patients while patients with nervous problems obtained fewer. Patients with new prescriptions on benzodiazepines obtained high-quantity prescriptions to a lesser extent than patients making repeat visits. In addition the study showed that it was not as common with high-quantity prescriptions in the three major cities and in the most sparsely populated communities as in mid-sized communities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426978     DOI: 10.1016/0277-9536(93)90018-y

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  5 in total

1.  Use of addictive anxiolytics and hypnotics in a national cohort of incident users in Norway.

Authors:  Svein R Kjosavik; Sabine Ruths; Steinar Hunskaar
Journal:  Eur J Clin Pharmacol       Date:  2011-09-18       Impact factor: 2.953

Review 2.  Customising an international disease management model to the needs of individual countries. Application to upper gastrointestinal disease.

Authors:  A Haycox; D Dubois; M Butterworth
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

3.  Carisoprodol use and abuse in Norway: a pharmacoepidemiological study.

Authors:  Jørgen G Bramness; Kari Furu; Anders Engeland; Svetlana Skurtveit
Journal:  Br J Clin Pharmacol       Date:  2007-02-12       Impact factor: 4.335

4.  Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors.

Authors:  Anne M Hausken; Kari Furu; Svetlana Skurtveit; Anders Engeland; Jørgen G Bramness
Journal:  Eur J Clin Pharmacol       Date:  2008-09-23       Impact factor: 2.953

5.  The total sale of prescription drugs with an abuse potential predicts the number of excessive users: a national prescription database study.

Authors:  Ingeborg Rossow; Jørgen G Bramness
Journal:  BMC Public Health       Date:  2015-03-25       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.